|
1
|
Moss C and Kaye SB: Ovarian cancer:
progress and continuing controversies in management. Eur J Cancer.
38:1701–1707. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Seraj MJ, Samant RS, Verderame MF and
Welch DR: Functional evidence for a novel human breast carcinoma
metastasis suppressor, BRMS1, encoded at chromosome 11q13. Cancer
Res. 60:2764–2769. 2000.PubMed/NCBI
|
|
3
|
Shevde LA, Samant RS, Goldberg SF,
Sikaneta T, Alessandrini A, Donahue HJ, Mauger DT and Welch DR:
Suppression of human melanoma metastasis by the metastasis
suppressor gene, BRMS1. Exp Cell Res. 273:229–239. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang S, Lin QD and Di W: Suppression of
human ovarian carcinoma metastasis by the metastasis-suppressor
gene, BRMS1. Int J Gynecol Cancer. 16:522–531. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen X, Xu Z and Wang Y: Recent advances
in breast cancer metastasis suppressor 1. Int J Biol Markers.
26:1–8. 2011. View Article : Google Scholar
|
|
6
|
DeWald DB, Torabinejad J, Samant RS,
Johnston D, Erin N, Shope JC, Xie Y and Welch DR: Metastasis
suppression by breast cancer metastasis suppressor 1 involves
reduction of phosphoinositide signaling in MDA-MB-435 breast
carcinoma cells. Cancer Res. 65:713–717. 2005.
|
|
7
|
Cicek M, Fukuyama R, Welch DR, Sizemore N
and Casey G: Breast cancer metastasis suppressor 1 inhibits gene
expression by targeting nuclear factor-kappaB activity. Cancer Res.
65:3586–3595. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Samant RS, Clark DW, Fillmore RA, Cicek M,
Metge BJ, Chandramouli KH, Chambers AF, Casey G, Welch DR and
Shevde LA: Breast cancer metastasis suppressor 1 (BRMS1) inhibits
osteopontin transcription by abrogating NF-κB activation. Mol
Cancer. 6:62007.PubMed/NCBI
|
|
9
|
Cicek M, Fukuyama R, Cicek MS, Sizemore S,
Welch DR, Sizemore N and Casey G: BRMS1 contributes to the negative
regulation of uPA gene expression through recruitment of HDAC1 to
the NF-κB binding site of the uPA promoter. Clin Exp Metastasis.
26:229–237. 2009.PubMed/NCBI
|
|
10
|
Hurst DR, Edmonds MD, Scott GK, Benz CC,
Vaidya KS and Welch DR: Breast cancer metastasis suppressor 1
up-regulates miR-146, which suppresses breast cancer metastasis.
Cancer Res. 69:1279–1283. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li J, Cheng Y, Tai D, Martinka M, Welch DR
and Li G: Prognostic significance of BRMS1 expression in human
melanoma and its role in tumor angiogenesis. Oncogene. 30:896–906.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang J, Zhang B, Lin Y, Yang Y, Liu X and
Lu F: Breast cancer metastasis suppressor 1 inhibits SDF-1α-induced
migration of non-small cell lung cancer by decreasing CXCR4
expression. Cancer Lett. 269:46–56. 2008.PubMed/NCBI
|
|
13
|
Kruizinga RC, Bestebroer J, Berghuis P, de
Haas CJ, Links TP, de Vries EG and Walenkamp AM: Role of chemokines
and their receptors in cancer. Curr Pharm Des. 15:3396–3416. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Manu KA, Shanmugam MK, Rajendran P, Li F,
Ramachandran L, Hay HS, Kannaiyan R, Swamy SN, Vail S, Kapoor S,
Ramesh B, Bist P, Koay ES, Lim LH, Ahn KS, Kumar AP and Sethi G:
Plumbagin inhibits invasion and migration of breast and gastric
cancer cells by downregulating the expression of chemokine receptor
CXCR4. Mol Cancer. 10:1072011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao BC, Wang ZJ, Mao WZ, Ma HC, Han JG,
Zhao B and Xu HM: CXCR4/SDF-1 axis is involved in lymph node
metastasis of gastric carcinoma. World J Gastroenterol.
17:2389–2396. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kajiyama H, Shibata K, Terauchi M, Ino K,
Nawa A and Kikkawa F: Involvement of SDF-1α/CXCR4 axis in the
enhanced peritoneal metastasis of epithelial ovarian carcinoma. Int
J Cancer. 122:91–99. 2008.
|
|
17
|
Chu CY, Cha ST, Lin WC, Lu PH, Tan CT,
Chang CC, Lin BR, Jee SH and Kuo ML: Stromal cell-derived factor-1
α (SDF-1 α/CXCL12)-enhanced angiogenesis of human basal cell
carcinoma cells involves ERK1/2-NF-κB/interleukin-6 pathway.
Carcinogenesis. 30:205–213. 2009.
|
|
18
|
Ping YF, Yao XH, Jiang JY, Zhao LT, Yu SC,
Jiang T, Lin MC, Chen JH, Wang B, Zhang R, Cui YH, Qian C, Wang J
and Bian XW: The chemokine CXCL12 and its receptor CXCR4 promote
glioma stem cell-mediated VEGF production and tumour angiogenesis
via PI3K/AKT signaling. J Pathol. 224:344–354. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Helbig G, Christopherson KW II,
Bhat-Nakshatri P, Kumar S, Kishimoto H, Miller KD, Broxmeyer HE and
Nakshatri H: NF-κB promotes breast cancer cell migration and
metastasis by inducing the expression of the chemokine receptor
CXCR4. J Bilo Chem. 278:21631–21638. 2003.
|
|
20
|
Chambers AF, Groom AC and MacDonald IC:
Dissemination and growth of cancer cells in metastatic sites. Nat
Rev Cancer. 2:563–572. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hedley BD, Vaidya KS, Phadke P, Mackenzie
L, Dales DW, Postenka CO, MacDonald IC and Chambers AF: BRMS1
suppresses breast cancer metastasis in multiple experimental models
of metastasis by reducing solitary cell survival and inhibiting
growth initiation. Clin Exp Metastasis. 25:727–740. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Phadke PA, Vaidya KS, Nash KT, Hurst DR
and Welch DR: BRMS1 suppresses breast cancer experimental
metastasis to multiple organs by inhibiting several steps of the
metastatic process. Am J Pathol. 172:809–817. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stark AM, Tongers K, Maass N, Mehdorn HM
and Held-Feindt J: Reduced metastasis-suppressor gene
mRNA-expression in breast cancer brain metastases. J Cancer Res
Clin Oncol. 131:191–198. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hicks DG, Yoder BJ, Short S, Tarr S,
Prescott N, Crowe JP, Dawson AE, Budd GT, Sizemore S, Cicek M,
Choueiri TK, Tubbs RR, Gaile D, Nowak N, Accavitti-Loper MA, Frost
AR, Welch DR and Casey G: Loss of breast cancer metastasis
suppressor 1 protein expression predicts reduced disease-free
survival in subsets of breast cancer patients. Clin Cancer Res.
12:6702–6708. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhao XL and Wang P: Expression of SATB1
and BRMS1 in ovarian serous adenocarcinoma and its relationship
with clinicopathological features. Sichuan Da Xue Xue Bao Yi Xue
Ban. 42:82–85. 1052011.(In Chinese).
|
|
26
|
Smith PW, Liu Y, Siefert SA, Moskaluk CA,
Petroni GR and Jones DR: Breast cancer metastasis suppressor 1
(BRMS1) suppresses metastasis and correlates with improved patient
survival in non-small cell lung cancer. Cancer Lett. 276:196–203.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Z, Yamashita H, Toyama T, Yamamoto
Y, Kawasoe T and Iwase H: Reduced expression of the breast cancer
metastasis suppressor 1 mRNA is correlated with poor progress in
breast cancer. Clin Cancer Res. 12:6410–6414. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Miyanishi N, Suzuki Y, Simizu S, Kuwabara
Y, Banno K and Umezawa K: Involvement of autocrine CXCL12/CXCR4
system in the regulation of ovarian carcinoma cell invasion.
Biochem Biophys Res Commun. 403:154–159. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chua AW, Hay HS, Rajendran P, Shanmugam
MK, Li F, Bist P, Koay ES, Lim LH, Kumar AP and Sethi G: Butein
downregulates chemokine receptor CXCR4 expression and function
through suppression of NF-κB activation in breast and pancreatic
tumor cells. Biochem Pharmacol. 80:1553–1562. 2010.PubMed/NCBI
|
